Compelling evidence support an involvement of oxidative stress and intestinal inflammation as early events in the predisposition and development of obesity and its related comorbidities. Here, we show that deficiency of the major mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2) in the gastrointestinal tract drives spontaneous obesity. Intestinal epithelium-specific Sod2 ablation in mice induced adiposity and inflammation via phospholipase A2 (PLA2) activation and increased release of omega-6 polyunsaturated fatty acid arachidonic acid. Remarkably, this obese phenotype was rescued when fed an essential fatty acid-deficient diet, which abrogates de novo biosynthesis of arachidonic acid. Data from clinical samples revealed that the negative correlation between intestinal Sod2 mRNA levels and obesity features appears to be conserved between mice and humans. Collectively, our findings suggest a role of intestinal Sod2 levels, PLA2 activity, and arachidonic acid in obesity presenting new potential targets of therapeutic interest in the context of this metabolic disorder.

Enterocyte superoxide dismutase 2 deletion drives obesity / O. Garcia-Irigoyen, F. Bovenga, M. Piglionica, E. Piccinin, M. Cariello, M. Arconzo, C. Peres, P.A. Corsetto, A.M. Rizzo, M. Ballanti, R. Menghini, G. Mingrone, P. Lefebvre, B. Staels, T. Shirasawa, C. Sabbà, G. Villani, M. Federici, A. Moschetta. - In: ISCIENCE. - ISSN 2589-0042. - 25:1(2022 Jan 21), pp. 103707.1-103707.18. [10.1016/j.isci.2021.103707]

Enterocyte superoxide dismutase 2 deletion drives obesity

P.A. Corsetto;A.M. Rizzo;
2022-01-21

Abstract

Compelling evidence support an involvement of oxidative stress and intestinal inflammation as early events in the predisposition and development of obesity and its related comorbidities. Here, we show that deficiency of the major mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2) in the gastrointestinal tract drives spontaneous obesity. Intestinal epithelium-specific Sod2 ablation in mice induced adiposity and inflammation via phospholipase A2 (PLA2) activation and increased release of omega-6 polyunsaturated fatty acid arachidonic acid. Remarkably, this obese phenotype was rescued when fed an essential fatty acid-deficient diet, which abrogates de novo biosynthesis of arachidonic acid. Data from clinical samples revealed that the negative correlation between intestinal Sod2 mRNA levels and obesity features appears to be conserved between mice and humans. Collectively, our findings suggest a role of intestinal Sod2 levels, PLA2 activity, and arachidonic acid in obesity presenting new potential targets of therapeutic interest in the context of this metabolic disorder.
lipid; molecular physiology; obesity medicine
Settore BIO/10 - Biochimica
27-dic-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2589004221016771-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 3.97 MB
Formato Adobe PDF
3.97 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/893246
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact